Coagulation factor ii, Coagulation factor ix, Antihemophilic factor, Coagulation factor x, Protein c, Protein s
Beriplex P/N 500
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substances
- Coagulation factor ii, Coagulation factor ix, Antihemophilic factor, Coagulation factor x, Protein c, Protein s
- Strength
- 800 UNIT + 620 UNIT + 500 UNIT + 1020 UNIT + 820 UNIT + 680 UNIT
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 28 Jul 2011
- Registration
- DIN 02359251
- Marketing authorisation holder
- CSL Behring Canada INC
- ATC code
- B02BD01
- Supply
- SCHEDULE D